Speaking to eFE, KLM Cargo director pharmaceutical logistics (the Netherlands) Sanjay Tiwari said transportation of biological material requires specialised carriers as they are high-end and comprise different products. Also, these goods require the right kind of packaging and solutions.
Earlier, elaborating on their joint effort to provide one-stop logistical solutions to Indian pharma and biotech companies, OPG Group managing director H Huppes, a 105-year old pharma logistics provider in Europe, said: We are entering the Indian market for the first time and find that it is diverse. Indian companies quality is good while China is years behind in this area and in the pharmaceutical sector compared to India.
China is simply not interesting, concurred Mr Tiwari. OPG is already serving big overseas companies like Novartis, Cipla, 3M, Sandoz and Indian majors like Ranbaxy and Dr Reddys. Now, along with KLM it has approached others like Wockhardt, GSK and Aurobindo Pharma among others, pointed out Ms Huppes.
KLM has also decided to provide controlled, chilled and frozen carriers required to ship these kind of material, he said.
Products such as serums, vaccines, pills and medical instruments are critical to the quality of life and health. These kind of material are subject to specific regulations in all countries for the safety of the public. Hence, Mr Tiwari pointed out that KLM Cargo is offering services with necessary transport conditions. The airline hopes to negotiate with biotech companies to cater to the specific needs of biotechnological products.